Efficacy of ormutivimab, a novel recombinant human anti-rabies monoclonal antibody, in post-exposure prophylaxis animal models.
第一作者:
Li-Li,Zhai
第一单位:
NCPC New Drug Research and Development Co., Ltd., State Key Laboratory of Antibody Research & Development, Shijiazhuang, 052165, Hebei Province, China.
作者:
主题词
动物(Animals);抗体, 单克隆(Antibodies, Monoclonal);抗体, 病毒(Antibodies, Viral);马(Horses);人类(Humans);模型, 动物(Models, Animal);暴露后预防(Post-Exposure Prophylaxis);狂犬病(Rabies);狂犬病疫苗(Rabies Vaccines);狂犬病病毒(Rabies virus)
DOI
10.1016/j.tmaid.2022.102267
PMID
35091118
发布时间
2022-03-24
- 浏览1
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文